B
BOLT
Bolt Biotherapeutics, Inc.
4.950
+0.360+7.84%After Hours: 4.800 -0.150 -3.03%18:20 05/22 EDT
OPEN/PREV CLOSE4.660/4.590
TODAY RANGE4.650-4.970
VOL22.15K
MARKET CAP9.51M
52 WEEK RANGE3.910-9.25
AVG VOL (3M)25.22K
% TURNOVER1.15%
TURNOVER--
P/E (TTM)-0.3029
% RANGE6.54%
EPS(TTM)-16.3397
P/E(FORWARD)-0.0141
P/B0.4799
BVPS10.32
DIVIDEND--
P/S1.235
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.84M
SHARES OUTSTANDING1.92M
NEXT EARNINGS08/12-08/17
FREE FLOAT1.78M
LOT SIZE1
EX-DATE06/09/2025
News
Press Releases
Financial Reports
Profile
Reuters·05/12 21:44
BRIEF-Bolt Biotherapeutics Reports First Quarter 2026 Financial Results
Seeking Alpha·05/12 20:53
Bolt Biotherapeutics GAAP EPS of -$4.31 misses by $1.46, revenue of $0.03M misses by $1.47M
Reuters·05/12 20:27
Bolt Biotherapeutics Q1 revenue drops, net loss narrows
Dow Jones·05/12 20:06
*Bolt Biotherapeutics 1Q Loss $7.24M >BOLT
Dow Jones·05/12 20:06
*Bolt Biotherapeutics 1Q Rev $26,000 >BOLT
Dow Jones·05/12 20:06
*Bolt Biotherapeutics: Cash on Hand Is Expected to Fund Ops Into 2027
Dow Jones·05/12 20:05
Press Release: Bolt Biotherapeutics Reports First -2-
Dow Jones·05/12 20:05
*Bolt Biotherapeutics 1Q Loss/Shr $4.31 >BOLT
PUBT·04/28 20:09
Bolt Biotherapeutics announces annual shareholder meeting
TipRanks·04/07 08:56
JonesTrading Keeps Their Hold Rating on Bolt Biotherapeutics (BOLT)
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.